SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ligand (LGND) Breakout!
An SI Board Since September 1996
Posts SubjectMarks Bans Symbol
32384 154 0 LGND
Emcee:  Henry Niman Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
31084Thanks I wasn't sure if that was the case. Appreciate the helpSPSEIFERT-6/11/2002
31083I am not sure I understand your question. ELN wants to sell the LGND shares it SemiBull-6/11/2002
31082What does this mean in layman's terms?SPSEIFERT-6/10/2002
31081Ligand Responds to Investor Questions Regarding Elan's Ligand Shares SAN DISemiBull-6/9/2002
31080Ligand Earns $1.1 Million Milestone Payment as Lilly IND for LY929 Clears FDA SSemiBull-6/4/2002
31079Clinical Studies of Targretin Capsules and ONTAK Presented at ASCO Underscore PoSemiBull-5/20/2002
31078Clinical Studies of Targretin Capsules and ONTAK Presented at ASCO Underscore PoSemiBull-5/20/2002
31077Thanks Tuck, HaroldHarold Engstrom-5/17/2002
31076One doesn't have to register for this, nor is there any language about embartuck-5/17/2002
31075Any PASI scores?Harold Engstrom-5/17/2002
31074I wonder what the ramifications of this will be for doctors who will prescribe tSPSEIFERT-5/17/2002
31073>>SAN DIEGO--(BW HealthWire)--May 17, 2002-- Treatment with Ligand's atuck-5/17/2002
31072S-3 related to recent private placement. Putnam was rumored to be in trouble antuck-5/14/2002
31071Ligand Pharmaceutical Extends Option To Buy X-Ceptor Therapeutics WASHINGTON -(SemiBull-5/7/2002
31070AVINZA Phase III Study Published in Leading Pain Journal Shows that New Drug RedSemiBull-5/2/2002
31069Ligand Reports Financial Results for First Quarter 2002: Total Revenues Up 46%, SemiBull-5/2/2002
31068Earnings Release on Friday.Arthur Radley-5/1/2002
31067Ligand Names Thomas H. Silberg Executive Vice President and Chief Operating OffiSemiBull-4/22/2002
31066Ligand to Receive $3 Million as Royalty Pharma Exercises First Option to PurchasSemiBull-4/18/2002
31065ONTAK Phase III Study Published in March Issue of Clinical Lymphoma Shows BetterSemiBull-4/18/2002
31064Thursday April 18, 8:33 am Eastern Time Press Release SOURCE: Ligand PharmaceutiArthur Radley-4/18/2002
31063Ligand Raises $69.3 Million in Private Placement of Common Stock SAN DIEGO--(BWSemiBull-4/17/2002
31062Ligand Raises $69.3 Million in Private Placement of Common Stock SAN DIEGO--(BWSemiBull-4/17/2002
31061Wednesday April 17, 10:18 am Eastern Time Press Release SOURCE: Ligand PharmaceuArthur Radley-4/17/2002
31060>>INDIANAPOLIS and SAN DIEGO--(BW HealthWire)--April 12, 2002-- Eli Lilly tuck-4/12/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News